Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Clinical, Pathological and Molecular Peculiarities of Lobular Breast Cancer"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (15 December 2021) | Viewed by 34981
Special Issue Editors
Interests: breast cancer; lobular breast cancer; genomics; transcriptomics; tumor microenvironment; obesity; adiposity; inflammatory breast cancer; cancer progression; dormancy
Interests: lobular breast cancer; cell adhesion; extra cellular matrix; metastasis; mouse models
Interests: molecular and phenotypical characteristics of breast cancer histological subtypes; pathology; lobular carcinoma; stroma
Special Issue Information
Invasive lobular breast cancer (ILC) represents the second most common histological subtype of invasive breast cancer. Large efforts in biomedical sciences and clinical research have yielded a wealth of data and insight into ILC development, diagnosis, progression, and responses to treatment. This knowledge has culminated in the awareness that ILC is a specific cancer type that should be recognized and treated as such.
There are nevertheless still important knowledge gaps with regard to this cancer type at the clinical, pathological, immune, and molecular level that need to be addressed. Implications of specific genomic alterations should be studied. The composition and role of the tumor microenvironment needs to be fully uncovered. Mechanisms explaining the long-term clinical dormancy observed in many of these ILC patients should be investigated. Additionally, adequate experimental models should be generated, properly described, and shared.
This Special Issue of Cancers therefore encompasses new research articles and timely reviews on all aspects of clinical, pathological, and molecular peculiarities of ILC.
Prof. Dr. Christine Desmedt
Prof. Dr. Patrick W. B. Derksen
Prof. Dr. Anne Vincent-Salomon
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- invasive lobular breast cancer
- tumor microenvironment
- experimental models
- single-cell characterization
- cancer progression